ADvantage Therapeutics logo
Therapeutics & Interventions

ADvantage Therapeutics

ADvantage Therapeutics is listed under Therapeutics & Interventions.

Developing novel therapeutics for neurodegenerative conditions, with a major focus on Alzheimer's disease.

Overview

ADvantage Therapeutics is developing novel therapeutics to treat neurodegenerative conditions with a major focus on Alzheimer's disease. Its lead therapeutic, AD04, modulates the immune system and is approved for Phase 2 clinical trials in Europe. The research team and laboratory are at the Vienna BioCenter.

Similar companies

Neuvana logo

Neuvana

Therapeutics & Interventions

Neuvana builds non-invasive neurostimulation technology that helps regulate the nervous system—improving how you recover, perform, and adapt to stress.

Ballancer Pro logo

Ballancer Pro

Therapeutics & Interventions

Ballancer®Pro is the world’s leading FDA-cleared compression therapy system. Experience the "Rolls-Royce of Lymphatic Massage" for detox, recovery, and wellness

Eng3 Corporation logo

Eng3 Corporation

Therapeutics & Interventions

Eng3 Corporation is a medical device company that develops NanoVi® biophysics technology designed to repair protein structures, and reduce oxidative stress